OTCMKTS:CNBX

Cannabics Pharmaceuticals News Headlines

Add
Compare
Today's Range N/A
50-Day Range
$0.18
$0.29
52-Week Range N/A
Volume110,863 shs
Average Volume395,279 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Cannabics Pharmaceuticals (OTCMKTS CNBX) News Headlines Today

SourceHeadline
Cannabics Pharmaceuticals to launch Drug Development Programs for Prostate Cancer and Neurodegenerative & Mental Health DiseasesCannabics Pharmaceuticals to launch Drug Development Programs for Prostate Cancer and Neurodegenerative & Mental Health Diseases
markets.businessinsider.com - June 17 at 8:22 AM
Cannabics Pharmaceuticals Launches a Breast Cancer Treatment Research ProgramCannabics Pharmaceuticals Launches a Breast Cancer Treatment Research Program
finance.yahoo.com - June 3 at 9:33 AM
Cannabics Pharmaceuticals Inc. (OTCMKTS:CNBX) Sees Significant Drop in Short InterestCannabics Pharmaceuticals Inc. (OTCMKTS:CNBX) Sees Significant Drop in Short Interest
americanbankingnews.com - May 29 at 3:20 PM
The European Patent Office Grants Cannabics Pharmaceuticals Patent for Companys Personalized Medicine Drug Discovery TechnologyThe European Patent Office Grants Cannabics Pharmaceuticals Patent for Company's Personalized Medicine Drug Discovery Technology
finance.yahoo.com - May 25 at 11:13 AM
Cannabics Pharmaceuticals Files a PCT Patent Application for Proprietary Cancer Treatment FormulationsCannabics Pharmaceuticals Files a PCT Patent Application for Proprietary Cancer Treatment Formulations
finance.yahoo.com - May 11 at 9:52 AM
Cannabics Pharmaceuticals Receives Patent "Notice of Allowance" From The Mexican Patent and Trademark Office (IMPI)Cannabics Pharmaceuticals Receives Patent "Notice of Allowance" From The Mexican Patent and Trademark Office (IMPI)
finance.yahoo.com - May 6 at 12:53 PM
USDA Teams Up With Illinois-Based Chemical Producer To Create Hemp-Based CosmeceuticalsUSDA Teams Up With Illinois-Based Chemical Producer To Create Hemp-Based 'Cosmeceuticals'
benzinga.com - May 1 at 9:27 AM
Cannabics Pharmaceuticals Launches a New Research Program to develop a Melanoma Treatment Drug Candidate for FDA Approval TrackCannabics Pharmaceuticals Launches a New Research Program to develop a Melanoma Treatment Drug Candidate for FDA Approval Track
finance.yahoo.com - April 26 at 1:16 PM
Cannabics Pharmaceuticals Launches Psilocybin and Psilocin Research ProgramCannabics Pharmaceuticals Launches Psilocybin and Psilocin Research Program
finance.yahoo.com - April 20 at 2:01 PM
Cannabics Pharmaceuticals to Initiate in-vivo Dose Response Study on Proprietary Colorectal Cancer Drug Candidate RCC-33Cannabics Pharmaceuticals to Initiate in-vivo Dose Response Study on Proprietary Colorectal Cancer Drug Candidate RCC-33
finance.yahoo.com - March 31 at 2:19 PM
Cannabics RCC-33 prolongs survival rate in mice inoculated with human colorectal cancer cellsCannabics' RCC-33 prolongs survival rate in mice inoculated with human colorectal cancer cells
seekingalpha.com - March 19 at 12:48 PM
Cannabics Pharmaceuticals Drug Candidate RCC-33 Prolongs Survival Rate in Mice Inoculated with Human Colorectal Cancer CellsCannabics Pharmaceuticals' Drug Candidate RCC-33 Prolongs Survival Rate in Mice Inoculated with Human Colorectal Cancer Cells
finance.yahoo.com - March 17 at 10:18 AM
Voyager Makes Dosing Simple, Safe And Precise To Optimize The Cannabis Experience Through Cannabis DropsVoyager Makes Dosing Simple, Safe And Precise To Optimize The Cannabis Experience Through Cannabis Drops
benzinga.com - March 11 at 8:53 AM
Gaard Labs Launches Several Lines Of CBD Products In The Big AppleGaard Labs Launches Several Lines Of CBD Products In The Big Apple
benzinga.com - February 25 at 7:04 PM
Cannabics Pharmaceuticals in-vivo Tumor Inhibitory Effect Study Concludes with a Statistical Significance of p ≤ 0.016Cannabics Pharmaceuticals' in-vivo Tumor Inhibitory Effect Study Concludes with a Statistical Significance of p ≤ 0.016
finance.yahoo.com - February 17 at 1:40 PM
Cannabics Pharmaceuticals in-vivo Study concludes with a 33% Lower Tumor Volume in Mice Treated with Companys Proprietary Drug Candidate for Colorectal CancerCannabics Pharmaceuticals' in-vivo Study concludes with a 33% Lower Tumor Volume in Mice Treated with Company's Proprietary Drug Candidate for Colorectal Cancer
finance.yahoo.com - February 16 at 2:22 PM
Cannabics Pharmaceuticals Interim in-vivo Study Results Show a 27% Lower Tumor Volume in Mice Treated with Companys Proprietary Drug Candidate for Colorectal CancerCannabics Pharmaceutical's Interim in-vivo Study Results Show a 27% Lower Tumor Volume in Mice Treated with Company's Proprietary Drug Candidate for Colorectal Cancer
finance.yahoo.com - February 3 at 9:48 AM
Klay Thompson, Alex Morgan, Travis Pastrana, Paul Rodriguez Talk About Their New CBD BrandKlay Thompson, Alex Morgan, Travis Pastrana, Paul Rodriguez Talk About Their New CBD Brand
benzinga.com - February 2 at 11:28 PM
How Will Psychedelics Become Medicine? A Scientific Review Of The Drug Development PathwayHow Will Psychedelics Become Medicine? A Scientific Review Of The Drug Development Pathway
benzinga.com - January 3 at 10:53 PM
News for Cannabics PharmaceuticalsNews for Cannabics Pharmaceuticals
markets.businessinsider.com - December 24 at 7:52 AM
Cannabics Pharmaceuticals Initiates In-Vivo Animal Studies for FDA Pre-IND Meeting PackageCannabics Pharmaceuticals Initiates In-Vivo Animal Studies for FDA Pre-IND Meeting Package
finance.yahoo.com - December 21 at 1:15 PM
Cannabics Pharmaceuticals announces a subsidiary Digestix BioscienceCannabics Pharmaceuticals announces a subsidiary Digestix Bioscience
seekingalpha.com - November 16 at 1:58 PM
Micro Cap Concludes Pre-Clinical Study for Cancer Drug CandidateMicro Cap Concludes Pre-Clinical Study for Cancer Drug Candidate
baystreet.ca - November 9 at 1:03 PM
Cannabics Concludes a Pre-Clinical Study on Human Biopsies in Preparation for FDA pre-IND Meeting Request on Colorectal Cancer Drug Candidate RCC-33Cannabics Concludes a Pre-Clinical Study on Human Biopsies in Preparation for FDA pre-IND Meeting Request on Colorectal Cancer Drug Candidate RCC-33
finance.yahoo.com - November 9 at 1:03 PM
Cannabics Pharmaceuticals Inc (CNBX)Cannabics Pharmaceuticals Inc (CNBX)
nasdaq.com - November 1 at 1:07 PM
Canada Health Minister Calls To Keep Injectable Opioid Therapy Treatment Program In Alberta OpenCanada Health Minister Calls To Keep Injectable Opioid Therapy Treatment Program In Alberta Open
benzinga.com - October 27 at 7:21 PM
Cannabics Pharmaceuticals receives "Intention to Grant a European Patent" notice for its System and Method for High Throughput Screening of Cancer Cells patent applicationCannabics Pharmaceuticals receives "Intention to Grant a European Patent" notice for its System and Method for High Throughput Screening of Cancer Cells patent application
finance.yahoo.com - October 27 at 2:17 PM
Cannabis Regulation Evolution In Ecuador: Sowing, Growing And Harvesting DecriminalizedCannabis Regulation Evolution In Ecuador: Sowing, Growing And Harvesting Decriminalized
benzinga.com - October 24 at 10:32 PM
Cannabics Pharmaceuticals Prepares to Submit the FDA with a pre-IND Meeting Request for its Proprietary Colon Cancer Drug Candidate, CANNABICS™ RCC-33Cannabics Pharmaceuticals Prepares to Submit the FDA with a pre-IND Meeting Request for its Proprietary Colon Cancer Drug Candidate, CANNABICS™ RCC-33
finance.yahoo.com - October 21 at 1:23 PM
Cannabics Pharmaceuticals to Establish a Division for its Antitumor Drug Candidate RCC-33Cannabics Pharmaceuticals to Establish a Division for its Antitumor Drug Candidate RCC-33
finance.yahoo.com - August 20 at 12:28 PM
Cannabics Pharmaceuticals Appoints Dr. Dana Ben-Ami Shor (MD), Gastroenterologist, to its Scientific Board of AdvisorsCannabics Pharmaceuticals Appoints Dr. Dana Ben-Ami Shor (MD), Gastroenterologist, to its Scientific Board of Advisors
finance.yahoo.com - August 5 at 12:22 PM
Cannabics Pharmaceuticals Initiates Penetration for Its Cannabinoid Diagnostic Platform Into European MarketsCannabics Pharmaceuticals Initiates Penetration for Its Cannabinoid Diagnostic Platform Into European Markets
finance.yahoo.com - July 14 at 9:32 AM
Cannabics Pharmaceuticals Appoints Dr. Erez Scapa, MD to its Scientific Board of AdvisorsCannabics Pharmaceuticals Appoints Dr. Erez Scapa, MD to its Scientific Board of Advisors
finance.yahoo.com - June 16 at 12:50 PM
Cannabics Pharmaceuticals expands portfolio through Cannomed collaborationCannabics Pharmaceuticals expands portfolio through Cannomed collaboration
seekingalpha.com - June 10 at 1:32 PM
Cannabics Pharmaceuticals and Cannomed Collaborate to Develop Cannabis Strains Targeting CancersCannabics Pharmaceuticals and Cannomed Collaborate to Develop Cannabis Strains Targeting Cancers
finance.yahoo.com - June 10 at 1:32 PM
Cannabics Pharmaceuticals to Capitalize on Israels Final Approval for the Export of Medical CannabisCannabics Pharmaceuticals to Capitalize on Israel's Final Approval for the Export of Medical Cannabis
finance.yahoo.com - May 26 at 9:47 AM
Cannabics Pharmaceuticals Files Provisional Patent on Composition and Method for Treating Colon Cancer With CannabinoidsCannabics Pharmaceuticals Files Provisional Patent on Composition and Method for Treating Colon Cancer With Cannabinoids
finance.yahoo.com - May 6 at 2:02 PM
Cannabics Pharmaceuticals Appoints Prof. Zamir Halpern to Its Scientific Board of AdvisorsCannabics Pharmaceuticals Appoints Prof. Zamir Halpern to Its Scientific Board of Advisors
finance.yahoo.com - April 27 at 11:29 AM
Cannabics Pharmaceuticals Inc.Cannabics Pharmaceuticals Inc.
www.barrons.com - April 26 at 10:49 PM
Cannabics Pharmaceuticals Develops Novel Cannabis Formulation for the Treatment of Colon CancerCannabics Pharmaceuticals Develops Novel Cannabis Formulation for the Treatment of Colon Cancer
finance.yahoo.com - April 13 at 1:59 PM
Cannabics Pharmaceuticals Study Shows Complex Combinatorial Anti-tumor Activity of CannabinoidsCannabics Pharmaceuticals Study Shows Complex Combinatorial Anti-tumor Activity of Cannabinoids
finance.yahoo.com - March 25 at 2:21 PM
Cannabics Pharma to offer HTS platform for SARS-CoV-2 researchCannabics Pharma to offer HTS platform for SARS-CoV-2 research
seekingalpha.com - March 18 at 2:02 PM
Cannabics Pharmaceuticals Offers Its High Throughput Screening (HTS) Platform to the Israeli Health Authorities for SARS-CoV-2 ResearchCannabics Pharmaceuticals Offers Its High Throughput Screening (HTS) Platform to the Israeli Health Authorities for SARS-CoV-2 Research
finance.yahoo.com - March 18 at 9:02 AM
Cannabics Pharmaceuticals Reveals Different Extraction Methods Result in Differential Necrotic Effects of Cannabis on Gastrointestinal Cancer CellsCannabics Pharmaceuticals Reveals Different Extraction Methods Result in Differential Necrotic Effects of Cannabis on Gastrointestinal Cancer Cells
finance.yahoo.com - March 2 at 1:13 PM
Cannabics Pharma, NewCanna Strike Agreement To Research Anti-Tumor Effects Of Ancestral Colombian StrainsCannabics Pharma, NewCanna Strike Agreement To Research Anti-Tumor Effects Of Ancestral Colombian Strains
www.benzinga.com - February 25 at 2:52 PM
Cannabics Pharmaceuticals to partner with NewCanna HubCannabics Pharmaceuticals to partner with NewCanna Hub
seekingalpha.com - February 25 at 2:52 PM
Cannabics Pharmaceuticals Partners With NewCanna to Commence Research Based on Colombian Indigenous Cannabis LandracesCannabics Pharmaceuticals Partners With NewCanna to Commence Research Based on Colombian Indigenous Cannabis Landraces
finance.yahoo.com - February 25 at 9:52 AM
Cannabics Pharmaceuticals Study Shows Cannabinoids CBNA and CBCA Cause Necrosis Similarly to their Non-acidic FormCannabics Pharmaceuticals Study Shows Cannabinoids CBNA and CBCA Cause Necrosis Similarly to their Non-acidic Form
finance.yahoo.com - February 18 at 12:39 PM
Cannabics Pharmaceuticals Collaborates With RCKMC to Develop Cannabis Strains Targeting Gastrointestinal CancersCannabics Pharmaceuticals Collaborates With RCKMC to Develop Cannabis Strains Targeting Gastrointestinal Cancers
finance.yahoo.com - February 11 at 9:11 AM
Cannabics Pharmaceuticals Study Shows Cannabinoids CBC and CBG ExhibitCannabics Pharmaceuticals Study Shows Cannabinoids CBC and CBG Exhibit
finance.yahoo.com - January 27 at 9:36 AM
This page was last updated on 6/19/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.